John Paulson’s $5,000 Gold Bet: Genius or Gamble? 🚀
80% in 4 Stocks: Inside Paulson’s High-Risk Portfolio 💰
John Paulson’s 2025 Portfolio: Gold Miners, Biotech, and the $5,000 Target 🚀
NASDAQ: MDGL | NASDAQ: PPTA | NYSE: BHC | NYSE: THM (as of early 2026)
🎯 FunFund Index™ : 8.3 / 10 🎯
Tooltip: A bold, high-conviction macro bet—massive upside if gold and biotech deliver, but concentration risk could bite harder than a bear market in a bad mood.
If hedge funds were movies, John Paulson would still be living off the royalties of The Greatest Trade Ever (2007 edition). But 2025 proves he’s not just a one-hit wonder—he’s back on stage, guitar in hand, betting big on gold, biotech, and conviction over diversification.
And when we say “big,” we mean:
👉 ~$3.2B+ equity portfolio
👉 Top 4 holdings = ~81% of the portfolio
👉 Turnover = 3% (aka… glacial patience)
This is not investing.
This is portfolio minimalism meets macro maximalism.
🧭 Zooming out
Curious how John Paulson stacks up against other top hedge funds — quants, activists, macro masters, and long-term legends? We maintain a living hedge fund ranking that’s updated regularly with fresh analysis, new coverage, and practical takeaways.
🧠 2025 Strategy: The “All-In, No Apologies” Playbook
Paulson has fully embraced life as a family office cowboy 🤠—no outside investors, no quarterly panic calls, no “please diversify” emails.
🥇 The Gold Thesis: $5,000 or Bust
Paulson’s headline call:
👉 Gold at $5,000/oz by 2028
Translation:
He’s not buying gold…
He’s buying the companies digging it out of the ground.
Key bets:
- Perpetua Resources Corp.
- Novagold Resources Inc.
- International Tower Hill Mines Ltd.
💡 ~$840M deployed into miners
👉 Why miners?
Because if gold goes up 2x… miners can go 5x+.
High beta. High drama. High reward.
💊 The Biotech Barbell: Genius Meets Gamble
On the other side of the portfolio:
-
Madrigal Pharmaceuticals Inc.
👉 ~29% position
👉 +126% gain
👉 The “golden child” -
Bausch Health Companies Inc.
👉 ~12% position
👉 -66%… 😬
👉 And yes… he added more
This is classic Paulson:
👉 Win big where you’re right
👉 Double down where you think you’re right
📊 The High-Conviction Dashboard
| Holding | Weight | Performance | Vibe |
|---|---|---|---|
| MDGL | 29.4% | +126.9% | 🧬 Biotech rocket |
| PPTA | 28.8% | +313.1% | 🥇 Gold on steroids |
| BHC | 12.4% | -66.4% | 🔪 Catching knives |
| NG / THM | ~15% | Strong gains | ⛏️ Macro leverage |
👉 Translation:
This portfolio doesn’t diversify risk…
It concentrates conviction.
🏆 Performance Context: From Legend to Reinvention
Let’s rewind.
- 2007–2010: Historic subprime bet → ~$15B profit 💰
- 2011–2019: Rough years, redemptions, volatility 📉
- 2020: Transition to family office 🔄
- 2023–2025: Comeback fueled by gold + biotech
👉 Recent gains: $600M+ (2023–2024)
👉 2025: Highest equity exposure in years
Paulson didn’t disappear.
He reset the game rules.
🎯 What Makes This Portfolio So… Paulson?
1️⃣ Concentration to the Extreme
Top 4 = 81%
Most investors panic at 10% in one stock.
Paulson basically says:
👉 “Why own 20 ideas when 4 will do?”
2️⃣ Event-Driven DNA Still Alive
Even with the gold obsession, his roots remain:
- Merger arbitrage
- Distressed bets
- Idiosyncratic plays
Translation:
👉 He’s still hunting mispriced chaos
3️⃣ Patience (a.k.a. The Anti-Wall-Street Trait)
Turnover: 3%
That’s not investing.
That’s watching paint dry… strategically.
😂 The FUNanc1al Interpretation
If this portfolio were a personality:
- Gold = 🏰 “I don’t trust the system”
- Biotech = 🧪 “But I trust science… selectively”
- Bausch = 🤕 “This will work… eventually…”
👉 It’s part macro hedge, part moonshot, part stubborn genius.
❓ FAQ
Q: Why is Paulson so bullish on gold?
👉 Inflation hedge, currency concerns, and macro uncertainty.
Q: Why miners instead of gold ETFs?
👉 Higher leverage = higher upside (and risk).
Q: Isn’t this portfolio too concentrated?
👉 Yes. That’s the point.
Q: What’s the biggest risk?
👉 Gold thesis fails + biotech volatility = double trouble.
⚡ Quick Take / TL;DR
- Paulson is running a high-conviction, concentrated portfolio
- Massive bet on gold hitting $5,000
- Biotech provides upside (and volatility)
- Minimal diversification, maximum conviction
👉 Verdict: A bold macro bet with asymmetric upside… and equally real downside.
🧠 Food for Thought: The Cross-Hub Connection
Paulson’s portfolio is less about stocks…
and more about psychology.
In a world of:
- constant news
- endless data
- short-term noise
He’s doing something rare:
👉 Holding fewer ideas… for longer
This applies beyond investing:
- In business → fewer bets, higher conviction
- In life → fewer distractions, deeper focus
Sometimes, the edge isn’t more.
It’s less—but better chosen.
✍️ About the Author
Frédéric Marsanne is the founder of FUNanc1al — part market analyst, part storyteller, part accidental comedian. A longtime investor, entrepreneur, and venture-builder across tech, biotech, and fintech, he now blends sharp insights with a twist of humor to help readers laugh, learn, live better lives, and invest a little wiser. When not decoding insider buys or poking fun at earnings calls, he’s building Cl1Q, writing fiction, painting, or discovering new passions to FUNalize.
🧾⚠️📢 Fun(anc1al) but Serious Disclaimer: 🧾⚠️📢
This article is for educational and entertainment purposes only—this is not investment advice, a recommendation, or a suggestion to bet your portfolio on gold miners and biotech moonshots (tempting though it may be).
Markets can go up, down, and sideways—sometimes all before lunch. Resist FOMO and never invest money you can’t afford to lose.
Hedge funds, quantitative strategies, and factor investing involve risk, including the risk of significant losses. Past performance is not indicative of future results. Always do your own research or consult a qualified financial advisor before making investment decisions.
We are not hedge fund managers. We do not wear parachutes to rooftop parties.
We laugh, we analyze, we meme.
We’re FUNancial advisors — not financial advisors. 😄📉📈
Invest at your own risk. Love at any pace. Laugh at every turn.
Be Happy, Stay Curious, and Carpe Diem. 😄😄😄
🧭 Looking for a Different Angle?
- 🕵️ Insider Purchases Center
- 📣 Follow the Pundits Hub
- 📈 Young Guns & Turnaround Stocks — Track More Growth (and Growing-Pain) Plays
- 😆 Stock Market Humor & Serious-ish Plays
- 🌍 See the world differently and check out more international market picks and fun takes. Explore International Investment Opportunities and value plays 💸 Cheap Stocks with (Maybe) Big Upside
😂 Laugh, Learn, Invest: funanc1al.com | Funanc1al: Where Even Finance Meets Funny
Other articles:
Quick links
Search
About/Leadership
Editorial Process
Privacy Policy
Refund Policy
Shipping Policy
Terms of Service
Contact us
About us
FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.

Got a thought? A tip? A tale? We’re all ears — drop it below.: